Literature DB >> 23969239

Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Y P Deng1, T Wong, C Bricker-Anthony, B Deng, A Reiner.   

Abstract

Motor slowing, forebrain white matter loss, and striatal shrinkage have been reported in premanifest Huntington's disease (HD) prior to overt striatal neuron loss. We carried out detailed LM and EM studies in a genetically precise HD mimic, heterozygous Q140 HD knock-in mice, to examine the possibility that loss of corticostriatal and thalamostriatal terminals prior to striatal neuron loss underlies these premanifest HD abnormalities. In our studies, we used VGLUT1 and VGLUT2 immunolabeling to detect corticostriatal and thalamostriatal (respectively) terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathology. VGLUT1+ axospinous corticostriatal terminals represented about 55% of all excitatory terminals in striatum, and VGLUT2+ axospinous thalamostriatal terminals represented about 35%, with VGLUT1+ and VGLUT2+ axodendritic terminals accounting for the remainder. In Q140 mice, a significant 40% shortfall in VGLUT2+ axodendritic thalamostriatal terminals and a 20% shortfall in axospinous thalamostriatal terminals were already observed at 1 month of age, but VGLUT1+ terminals were normal in abundance. The 20% deficiency in VGLUT2+ thalamostriatal axospinous terminals persisted at 4 and 12 months in Q140 mice, and an additional 30% loss of VGLUT1+ corticostriatal terminals was observed at 12 months. The early and persistent deficiency in thalamostriatal axospinous terminals in Q140 mice may reflect a development defect, and the impoverishment of this excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. The loss of corticostriatal terminals at 1 year in Q140 mice is consistent with prior evidence from other mouse models of corticostriatal disconnection early during progression, and can explain both the measurable bradykinesia and striatal white matter loss in late premanifest HD.
© 2013.

Entities:  

Keywords:  Corticostriatal; Huntington's disease; Pathology; Premanifest; Thalamostriatal

Mesh:

Substances:

Year:  2013        PMID: 23969239      PMCID: PMC3808190          DOI: 10.1016/j.nbd.2013.08.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  139 in total

1.  Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.

Authors:  Yun-Ping Deng; Wan-Long Lei; Anton Reiner
Journal:  J Chem Neuroanat       Date:  2006-08-17       Impact factor: 3.052

2.  Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene.

Authors:  M Kusakabe; L Mangiarini; E D Laywell; G P Bates; A Yoshiki; N Hiraiwa; J Inoue; D A Steindler
Journal:  J Comp Neurol       Date:  2001-02-19       Impact factor: 3.215

3.  Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.

Authors:  Sarah A J Reading; Michael A Yassa; Arnold Bakker; Adam C Dziorny; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; Elizabeth H Aylward; Jason Brandt; Susumu Mori; Peter van Zijl; Susan S Bassett; Christopher A Ross
Journal:  Psychiatry Res       Date:  2005-09-30       Impact factor: 3.222

4.  Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.

Authors:  O Hansson; A Petersén; M Leist; P Nicotera; R F Castilho; P Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

5.  Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease.

Authors:  H Heinsen; U Rüb; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; H Korr; C Schmitz
Journal:  Acta Neuropathol       Date:  1999-06       Impact factor: 17.088

6.  Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

Authors:  S J Augood; R L Faull; P C Emson
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

7.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Spatial organization of patch and matrix compartments in the rat striatum.

Authors:  M Desban; M L Kemel; J Glowinski; C Gauchy
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

9.  Single-axon tracing study of corticostriatal projections arising from primary motor cortex in primates.

Authors:  Martin Parent; André Parent
Journal:  J Comp Neurol       Date:  2006-05-10       Impact factor: 3.215

10.  Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.

Authors:  S M de la Monte; J P Vonsattel; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

View more
  50 in total

1.  Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu u Imaging of Cortical Afferents in the Striatum of Normal and Huntington (Q175) Mice.

Authors:  Anton Dvorzhak; Nordine Helassa; Katalin Török; Dietmar Schmitz; Rosemarie Grantyn
Journal:  J Neurosci       Date:  2019-02-28       Impact factor: 6.167

Review 2.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

3.  Morphological Study of the Cortical and Thalamic Glutamatergic Synaptic Inputs of Striatal Parvalbumin Interneurons in Rats.

Authors:  Xuefeng Zheng; Liping Sun; Bingbing Liu; Ziyun Huang; Yaofeng Zhu; Tao Chen; Linju Jia; Yanmei Li; Wanlong Lei
Journal:  Neurochem Res       Date:  2021-03-26       Impact factor: 3.996

Review 4.  Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.

Authors:  Baljit S Khakh; Vahri Beaumont; Roger Cachope; Ignacio Munoz-Sanjuan; Steven A Goldman; Rosemarie Grantyn
Journal:  Trends Neurosci       Date:  2017-05-31       Impact factor: 13.837

5.  Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.

Authors:  Anna Parievsky; Cindy Moore; Talia Kamdjou; Carlos Cepeda; Charles K Meshul; Michael S Levine
Journal:  Neurobiol Dis       Date:  2017-07-27       Impact factor: 5.996

Review 6.  Molecular insights into cortico-striatal miscommunications in Huntington's disease.

Authors:  Matthew B Veldman; X William Yang
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

7.  Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Courtney L Burroughs; Stephen Cavaliere; Scott J Barton; Shirley Chen; X William Yang; George V Rebec
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

8.  Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Authors:  Stephen C Fowler; Nancy A Muma
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

9.  A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice.

Authors:  Natalie H Guley; Joshua T Rogers; Nobel A Del Mar; Yunping Deng; Rafiqul M Islam; Lauren D'Surney; Jessica Ferrell; Bowei Deng; Jessica Hines-Beard; Wei Bu; Huiling Ren; Andrea J Elberger; Jeffrey G Marchetta; Tonia S Rex; Marcia G Honig; Anton Reiner
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

10.  Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits.

Authors:  Spencer U McKinstry; Yonca B Karadeniz; Atesh K Worthington; Volodya Y Hayrapetyan; M Ilcim Ozlu; Karol Serafin-Molina; W Christopher Risher; Tuna Ustunkaya; Ioannis Dragatsis; Scott Zeitlin; Henry H Yin; Cagla Eroglu
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.